GITR Agonist Enhances Vaccination Responses in Lung Cancer

OncoImmunology - United States
doi 10.4161/2162402x.2014.992237
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Radiotherapy Enhances Responses of Lung Cancer to CTLA-4 Blockade

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

GITR Co-Signal in ILC2 Controls Allergic Lung Inflammation

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Chitosan Solution Enhances Both Humoral and Cell-Mediated Immune Responses to Subcutaneous Vaccination

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer

OncoImmunology
OncologyAllergyImmunology
2013English

Curcumin Enhances the Anti-Cancer Effects of Paris Saponin II in Lung Cancer Cells

Cell Proliferation
MedicineCell Biology
2018English

GSH Depletion Enhances Adenoviral Bax-Induced Apoptosis in Lung Cancer Cells

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2004English

Podoplanin Enhances Lung Cancer Cell Growth in Vivo by Inducing Platelet Aggregation

Scientific Reports
Multidisciplinary
2017English

Vorinostat Enhances the Cisplatin-Mediated Anticancer Effects in Small Cell Lung Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Γ-Secretase Inhibitor Enhances Antitumour Effect of Radiation in Notch-Expressing Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy